Please try another search
Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. Mabion S.A. was founded in 2007 and is based in Konstantynów Lódzki, Poland.
Name | Age | Since | Title |
---|---|---|---|
Robert Konski | - | - | Independent Chairman of Supervisory Board |
Zofia Szewczuk | - | - | Independent Member of the Supervisory Board |
Wojciech Wosko | - | - | Member of the Supervisory Board |
Józef Banach | - | 2018 | Independent Member of the Supervisory Board |
David John James | - | 2017 | Independent Member of Supervisory Board |
Slawomir Kosciak | - | 2022 | Independent Deputy Chairman of Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review